Mazdutide vs Semaglutide

Mazdutide is an experimental GLP-1 and glucagon dual-action drug still in development, with no FDA approvals yet. Semaglutide, sold under brand names like Ozempic and Wegovy, is an FDA-approved GLP-1-only treatment for type 2 diabetes, obesity, chronic kidney disease, and cardiovascular risk reduction. The main practical difference is that Mazdutide is not yet available, while Semaglutide is taken as an injection or oral pill, depending on the brand.

AI summary of the sources below.